Objectives-To observe one general practice's attempt to reduce prescribing costs on becoming third wave fundholders through the introduction of a generic formulary applied to all new and repeat prescribing.
To assess the impact on patients and prescribing patterns.
Design-An observational study using interviews with patients and practitioners ; questionnaires for patients and prescribing data.
Setting-One urban general practice with five partners in Scotland.
It became fundholding in April 1993.
Subjects-71 searches of the register of repeat prescriptions identified 1274 potential changes in drugs.
Questionnaires were sent to a stratified random sample of 280 patients four months after the changes were made ; 33 interviews were conducted with 17 patients selected by local pharmacists to represent a wide range of opinion.
Main outcome measures-Changes in prescribing and response and satisfaction of patients.
Of intended changes, 129 (70%) were inplace after four months.
Thirty three (20%) of the 167 patients who returned questionnaires were « very unhappy, » though interviews suggested that this was primarily with the communication they received rather than the change itself.
Generic prescribing rose from one in three (37%) to over a half (58%).
Mots-clés Pascal : Economie santé, Angleterre, Prescription médicale, Médecin généraliste, Coût, Homme, Chimiothérapie, Médicament générique, Grande Bretagne, Royaume Uni, Europe
Mots-clés Pascal anglais : Health economy, England, Medical prescription, General practitioner, Costs, Human, Chemotherapy, Great Britain, United Kingdom, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0191675
Code Inist : 002B30A01C. Création : 09/06/1995.